Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about JNJ

Recent news which mentions JNJ

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
This Magnificent Dividend Stock Is as Healthy as It Gets
Tickers JNJ
Tags Recent Press Releases Market News JNJ
From Motley Fool
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
Tickers JNJ NEWS
Tags Market News Analyst Ratings Benzinga
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags JNJ Market News BMY
From Motley Fool
Cancer Drugs Propel J&J Beyond Wall Street Estimates
Tickers JNJ WBA
Tags General Biotech WBA
From Benzinga
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
Tickers JNJ
Tags JNJ Market News Recent Press Releases
From Motley Fool
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
Tickers CDNA ERIC JNJ MGTX
Tags JNJ Markets PEGY
From Benzinga
Chipmaker Stocks Sink On ASML Earnings Leak, Oil Eyes Worst 1-Day Drop This Year, Small Caps Rally: What's Driving Markets Tuesday?
Tickers AAL ARM ASML BAC
Tags CCL UAL Tech
From Benzinga
Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
Tickers AAPL AMZN BAC CEG
Tags QQQ AMZN GOOG
From Benzinga
Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition
Tickers JNJ NEWS
Tags General News Briefs
From Benzinga
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
Tickers AMD BA BAC C
Tags Economics JBHT AMD
From Benzinga
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
Tickers BAC C GS JBHT
Tags Expert Ideas Jim Cramer Top Stories
From Benzinga
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Tickers JNJ NEWS
Tags Markets Expert Ideas JNJ
From Benzinga
This Is What Whales Are Betting On Johnson & Johnson
Tickers JNJ
Tags Markets BZI/UOA JNJ
From Benzinga
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
Tickers JNJ LLY NEWS
Tags JNJ Stories That Matter General
From Benzinga
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
Tickers JNJ NEWS
Tags News Earnings Technicals
From Benzinga
Columbus Day: Is Stock Market Open Today?
Tickers ABT BAC JNJ NEWS
Tags News QQQ ABT
From Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
Tickers AMZN CHD CLX JNJ
Tags Market News KO PEP
From Motley Fool
Market Whales and Their Recent Bets on JNJ Options
Tickers JNJ
Tags Benzinga Options Market News
From Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Tickers BX GS GSK HLN
Tags Health Care GS Large Cap
From Benzinga
What Analysts Are Saying About Johnson & Johnson Stock
Tickers JNJ
Tags Analyst Ratings JNJ Market News
From Benzinga
Insights Into Johnson &amp; Johnson's Performance Versus Peers In Pharmaceuticals Sector
Tickers JNJ NEWS
Tags Benzinga Trading Ideas News
From Benzinga
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income
Tickers AAPL AVGO JNJ JPM
Tags PG MA JNJ
From Motley Fool
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?
Tickers JNJ NEWS
Tags Price Target Earnings Briefs
From Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
Tickers JNJ NEWS TAK
Tags News Briefs Large Cap
From Benzinga
2 Smart Income Stocks to Buy Right Now
Tickers JNJ KO
Tags JNJ Market News Recent Press Releases
From Motley Fool
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
Tickers JNJ
Tags Benzinga Options Market News
From Benzinga
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Tickers JNJ NEWS PFE
Tags Equities Large Cap Biotech
From Benzinga
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
Tickers JNJ LEGN NEWS
Tags Market News Analyst Ratings Benzinga
From Benzinga
2 Excellent Dividend Stocks to Buy With Less Than $200
Tickers ABT JNJ
Tags Recent Press Releases Market News ABT
From Motley Fool
Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
Tickers JNJ NEWS
Tags Briefs News Biotech
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.